Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyanide Poisoning Compromises Gene Pathways Modulating Cardiac Injury in Vivo. | Chem Res Toxicol | 2021 | 33914522 | PubTator, text mining | PubMed |
| Immune-mediated entities of (primary) focal segmental glomerulosclerosis. | Cell Tissue Res | 2021 | 33907872 | PubTator, text mining | PubMed |
| Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules. | BMC Endocr Disord | 2021 | 33902539 | PubTator, text mining | PubMed |
| Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities. | Pharmacol Ther | 2021 | 33895190 | PubTator, text mining | PubMed |
Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2021 | 33889154 | PubTator, text mining | PubMed |
| Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia. | Sci Rep | 2021 | 33888767 | PubTator, text mining | PubMed |
| Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management. | Biomol Ther (Seoul) | 2021 | 33888647 | PubTator, text mining | PubMed |
| Arena3Dweb: interactive 3D visualization of multilayered networks. | Nucleic Acids Res | 2021 | 33885790 | PubTator, text mining | PubMed |
| Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans. | Transl Psychiatry | 2021 | 33879769 | PubTator, text mining | PubMed |
| Functional NMDA receptors are expressed by human pulmonary artery smooth muscle cells. | Sci Rep | 2021 | 33859248 | PubTator, text mining | PubMed |
| The Influence of Bosentan on MicroRNA-27a/PPARγ/ET-1 Signaling Pathway in Pulmonary Artery Hypertension. | Pediatr Cardiol | 2021 | 33856498 | PubTator, text mining | PubMed |
| Paracrine interleukin-8 affects mesenchymal stem cells through the Akt pathway and enhances human umbilical vein endothelial cell proliferation and migration. | Biosci Rep | 2021 | 33843989 | PubTator, text mining | PubMed |
| Overcoming Chemoresistance via Extracellular Vesicle Inhibition. | Front Mol Biosci | 2021 | 33842540 | PubTator, text mining | PubMed |
| Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | 33842514 | PubTator, text mining | PubMed |
| Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer. | Front Oncol | 2021 | 33842315 | PubTator, text mining | PubMed |
| Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension. | Cells | 2021 | 33805595 | PubTator, text mining | PubMed |
| Endothelial Glycocalyx as a Regulator of Fibrotic Processes. | Int J Mol Sci | 2021 | 33804258 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis. | Biomolecules | 2021 | 33803224 | PubTator, text mining | PubMed |
| Secondary Metabolites of Plants as Modulators of Endothelium Functions. | Int J Mol Sci | 2021 | 33802468 | PubTator, text mining | PubMed |
| THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner. | Cancers (Basel) | 2021 | 33802282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=59